Cimed

Cimed is one of the largest pharmaceutical companies in Brazil, ranking fourth in the national industry and specializing in the production of generic medicines, over-the-counter (OTC) products, and consumer health goods. The company operates a highly verticalized business model, managing everything from internal research and development to an extensive proprietary distribution network that reaches over 98% of Brazilian pharmacies. Cimed is widely recognized for its high-profile consumer brands, including Lavitan vitamins and the viral Carmed lip balm series, as well as its massive manufacturing hub in Pouso Alegre. Recently, the company has expanded into the hygiene and beauty segments and announced strategic plans to enter the semaglutide (generic Ozempic) market following future patent expirations.